Positions

Overview

  • Marshall M. Urist, M.D. is the Vice-Chairman of Education for the Department of Surgery at the UAB. He is a native Californian who joined the UAB faculty in 1981 after completing his medical education and surgical training at the University of Chicago, the Johns Hopkins Hospital and the University of California at Los Angeles. He headed the Section of Surgical Oncology from 1985 to 2007. He was the director of the general surgery residency program from 1991 to 2012. His major activities center around surgical education, clinical trials and patient care. He served as Director of the American Board of Surgery and was Chairman of the Surgical Oncology Advisory Council of the ABS. He has been active in raising educational standards in surgical oncology as chairman of the Training Committee of the Society of Surgical Oncology and as an officer of the Commission on Cancer of the American College of Surgeons. He is the author or co-author of over 100 journal publications and 40 textbook chapters. Over the past 34 years, he has contributed to the organization, oversight and accessions for cancer clinical trials at the regional, national and international levels.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Treatment patterns for ductal carcinoma in situ with close or positive mastectomy marginsJournal of Surgical Research.  231:36-42. 2018
    2016 NCCN Guidelines ® insights: Melanoma, version 3.2016: Featured updates to the NCCN GuidelinesJournal of the National Comprehensive Cancer Network.  14:945-958. 2016
    2016 NCCN Guidelines Insights: Melanoma, Version 3.2016.Journal of the National Comprehensive Cancer Network.  14:945-958. 2016
    2016 Basal cell skin cancer, version 1.2016: Clinical practice guidelines in oncologyJournal of the National Comprehensive Cancer Network.  14:574-597. 2016
    2016 Final Results of the Sunbelt Melanoma trial: A multi-institutional prospective randomized phase III study evaluating the role of adjuvant high-dose interferon alfa-2b and completion lymph node dissection for patients staged by sentinel lymph node biopsyJournal of Clinical Oncology.  34:1079-1086. 2016
    2016 Melanoma, version 2.2016 clinical practice guidelines in oncologyJournal of the National Comprehensive Cancer Network.  14:450-473. 2016
    2014 Dermatofibrosarcoma protuberans, version 1.2014Journal of the National Comprehensive Cancer Network.  12:863-868. 2014
    2014 Melanoma, version 4.2014.Journal of the National Comprehensive Cancer Network.  12:621-629. 2014
    2014 Melanoma, version 4.2014: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  12:621-629. 2014
    2014 Merkel cell carcinoma, version 1.2014.Journal of the National Comprehensive Cancer Network.  12:410-424. 2014
    2014 What is a clear margin in breast conserving cancer surgery?Current Treatment Options in Oncology.  15:79-85. 2014
    2013 Diversity of stage III melanoma in the era of sentinel lymph node biopsyAnnals of Surgical Oncology.  20:956-963. 2013
    2013 Melanoma, version 2.2013: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  11:395-407. 2013
    2012 A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: Comparison with the American joint committee on cancer modelJournal of The American College of Surgeons.  214:608-617. 2012
    2012 Dermatofibrosarcoma protuberansJournal of the National Comprehensive Cancer Network.  10:312-318. 2012
    2012 MelanomaJournal of the National Comprehensive Cancer Network.  10:366-400. 2012
    2011 Descriptive operative reports: Teaching, learning, and milestones to safe surgeryCurrent Surgery.  68:452-458. 2011
    2011 Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.Journal of Clinical Oncology.  29:e11048. 2011
    2011 DiscussionJournal of The American College of Surgeons.  212:460-462. 2011
    2011 The University of Alabama at Birmingham: School of Medicine and Department of SurgeryAmerican Surgeon.  77:10-18. 2011
    2010 Surveillance after surgical treatment of melanoma: Futility of routine chest radiographySurgery.  148:711-717. 2010
    2010 Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancerClinical Breast Cancer.  10:275-280. 2010
    2010 Prognostic information from sentinel lymph node biopsy in patients with thick melanomaArchives of Surgery -New York-.  145:622-627. 2010
    2010 Second primary melanomas: Incidence and outcomeAmerican Surgeon.  76:675-681. 2010
    2010 Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?Cancer.  116:1535-1544. 2010
    2010 Factors associated with false-negative sentinel lymph node biopsy in melanoma patientsAnnals of Surgical Oncology.  17:709-717. 2010
    2010 Basal cell and squamous cell skin cancersJournal of the National Comprehensive Cancer Network.  8:836-864. 2010
    2010 Ulceration as a predictive marker for response to adjuvant interferon therapy in melanomaAnnals of Surgery.  252:460-465. 2010
    2009 Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomasBreast Journal.  15:521-523. 2009
    2009 DiscussionAmerican Surgeon.  75:549-550. 2009
    2009 DiscussionAmerican Surgeon.  75:595-597. 2009
    2009 MelanomaJournal of the National Comprehensive Cancer Network.  7:250-275. 2009
    2009 Merkel cell carcinomaJournal of the National Comprehensive Cancer Network.  7:322-332. 2009
    2008 Board certification in surgical oncology: ABS certification is not the answer for surgical oncologyJournal of Surgical Oncology.  98:3. 2008
    2008 Effect of multiple-nodal basin drainage on cutaneous melanomaArchives of Surgery -New York-.  143:632-637. 2008
    2007 Factors Associated With Improved Survival Among Young Adult Melanoma Patients Despite a Greater Incidence of Sentinel Lymph Node MetastasisJournal of Surgical Research.  143:164-168. 2007
    2007 Thyroid carcinomaJournal of the National Comprehensive Cancer Network.  5:568-621. 2007
    2007 Basal cell and squamous cell skin cancersJournal of the National Comprehensive Cancer Network.  5:506-529. 2007
    2007 Dermatofibrosarcoma protuberansJournal of the National Comprehensive Cancer Network.  5:550-555. 2007
    2006 Melanoma.Journal of the National Comprehensive Cancer Network.  4:666-684. 2006
    2006 Melanoma: Clinical practice guidelines in oncology™Journal of the National Comprehensive Cancer Network.  4:666-684. 2006
    2006 Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcomaCancer.  107:371-379. 2006
    2006 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanomaJournal of Clinical Oncology.  24:2849-2857. 2006
    2006 Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer.Journal of Clinical Oncology.  24:10622. 2006
    2006 Gender-related differences in outcome for melanoma patientsAnnals of Surgery.  243:693-698. 2006
    2005 Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancerAnnals of Surgery.  241:941-947. 2005
    2005 E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7Molecular Carcinogenesis.  43:13-17. 2005
    2004 Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort studyAnnals of Surgery.  239:828-840. 2004
    2004 Treatment options for merkel cell carcinomaJournal of the National Comprehensive Cancer Network.  2:89-92. 2004
    2003 Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomasAnnals of Surgical Oncology.  10:190-195. 2003
    2003 Laparoscopic adrenalectomy and splenectomy are safe and reduce hospital stay and chargesAmerican Surgeon.  69:377-381. 2003
    2003 Results of long-term follow-up for transanal excision for rectal cancerAmerican Surgeon.  69:675-678. 2003
    2003 Axillary Lymph Node Status, but Not Tumor Size, Predicts Locoregional Recurrence and Overall Survival after Mastectomy for Breast CancerAnnals of Surgery.  237:732-739. 2003
    2003 Local recurrence after breast conserving therapy for invasive breast cancer: Analysis of prognostic factorsClinical and Translational Oncology.  5:93-97. 2003
    2003 Melanoma and sentinel nodes.Current Surgery.  60:16-20. 2003
    2002 Occult breast carcinoma presenting with axillary lymph node metastasesRevista de Investigacion Clinica.  54:204-208. 2002
    2002 Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancerAnnals of Surgery.  235:814-819. 2002
    2001 Sentinel node biopsy for cutaneous melanoma in the head and neckAnnals of Surgical Oncology.  8:716-719. 2001
    2001 Sentinel node biopsy for cutaneous melanoma in the head and neck.Annals of Surgical Oncology.  8:716-719. 2001
    2001 Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging systemJournal of Clinical Oncology.  19:3622-3634. 2001
    2001 Role of matrix metalloproteinases in colorectal carcinogenesisAnnals of Surgery.  233:786-792. 2001
    2001 Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53Annals of Surgery.  233:630-638. 2001
    2001 Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas.Annals of Surgical Oncology.  8:101-108. 2001
    2001 Reducing the cost of diagnosis of breast carcinoma: Impact of ultrasound and imaging-guided biopsies on a clinical breast practiceCancer.  91:324-332. 2001
    2001 Colorectal hepatic metastases: Resection, local ablation, and hepatic artery infusion pump are associated with prolonged survivalArchives of Surgery -New York-.  136:318-323. 2001
    2001 Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomasAnnals of Surgical Oncology.  8:101-108. 2001
    2001 Multimodality Treatment for Patients with Hepatocellular Carcinoma: Analysis of Prognostic Factors in a Single Western Institution SeriesJournal of Gastrointestinal Surgery.  5:638-645. 2001
    2001 Multimodality treatment of merkel cell carcinoma: Case series and literature review of 1024 casesAnnals of Surgical Oncology.  8:204-208. 2001
    2000 Extent of surgery for intermediate-risk well-differentiated thyroid cancerAmerican Journal of Surgery.  179:51-56. 2000
    2000 Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology.  7:87-97. 2000
    2000 Primary gastrointestinal sarcomasAmerican Surgeon.  66:1171-1175. 2000
    1999 Merkel cell carcinoma occurring in renal transplant patientsJournal of The American Academy of Dermatology.  41:289-291. 1999
    1999 Merkel cell carcinoma occurring in renal transplant patients.Journal of The American Academy of Dermatology.  41:289-291. 1999
    1999 MelanomaCancer Case Presentations: The Tumor Board.  3:1-11. 1999
    1999 T1 and t2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissectionHead & neck surgery.  21:124-130. 1999
    1998 NGGN Melanoma Practice GuidelinesOncology.  12:153-177. 1998
    1998 Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trialJournal of The American College of Surgeons.  187:69-79. 1998
    1998 Factors affecting survival following local, regional, or distant recurrence from localized melanomaJournal of Surgical Oncology.  67:228-233. 1998
    1998 Factors affecting survival following local, regional, or distant recurrence from localized melanoma.Journal of Surgical Oncology.  67:228-233. 1998
    1998 Clinical outcomes of localized melanoma of the foot: A case-control studyJournal of Clinical Epidemiology.  51:853-857. 1998
    1997 Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: Second interim analysis of data from a phase III, multi- institutional trialAnnals of Surgery.  226:198-206. 1997
    1997 Classification of localized melanoma by the exponential survival trees methodCancer.  79:1122-1128. 1997
    1997 Classification of localized melanoma by the exponential survival trees method.Cancer.  79:1122-1128. 1997
    1996 Management of patients with intermediate-thickness melanomaAnnual Review of Medicine.  47:211-217. 1996
    1996 Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trialAnnals of Surgical Oncology.  3:446-452. 1996
    1996 Surgical management of primary cutaneous melanomaCA: A Cancer Journal for Clinicians.  46:217-224. 1996
    1995 A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanomaCancer.  75:34-42. 1995
    1995 Melanoma recurrence surveillance patient or physician based?Annals of Surgery.  221:566-571. 1995
    1995 Needle-localization biopsy of the breast: Impact of a selective core needle biopsy program on yieldRadiology.  195:627-631. 1995
    1995 Oncologic Aspects of Autogenous Breast ReconstructionBreast Journal.  1:36-41. 1995
    1995 Prognostic factors in minor salivary gland cancerHead & neck surgery.  17:480-486. 1995
    1995 Workup of a patient with a mass in the neck.Advances in Surgery.  28:371-383. 1995
    1994 Insurance coverage of patients with breast cancer in the 1991 Commission on Cancer patient care evaluation studyAnnals of Surgical Oncology.  1:462-467. 1994
    1994 The National Cancer Data Base. Report on melanoma.Cancer.  74:782-788. 1994
    1994 1991 National survey of carcinoma of the breast by the commission on cancerJournal of The American College of Surgeons.  178:213-219. 1994
    1994 Patterns of care for younger women with breast cancer.JNCI Monographs.  43-46. 1994
    1994 The national cancer data base. Report on melanomaCancer.  74:782-788. 1994
    1993 Clinical, radiographic, and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ, and ductal carcinoma in situ with micro-invasionBreast.  2:21-26. 1993
    1993 Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancerHuman Antibodies.  4:190-197. 1993
    1992 Predicting survival and recurrence in localized melanoma: A multivariate approachWorld Journal of Surgery.  16:191-195. 1992
    1992 Paragangliomas of the NeckArchives of Surgery -New York-.  127:1441-1445. 1992
    1992 Prognostic significance of cervical lymph node metastases in differentiated thyroid cancerAmerican Journal of Surgery.  164:578-581. 1992
    1991 Lack of effect of pregnancy on outcome of melanomaLancet.  337:653-655. 1991
    1991 Metastatic malignant fibrohistiocytic tumors masquerading as pleura-based cyst-like lesions.Journal of the National Medical Association.  83:513-516. 1991
    1990 Histopathological prognostic factors of certain primary oral cavity cancers.Oncology.  4:39-45. 1990
    1990 Florid papillomatosis of the nipple: immunohistochemical and flow cytometric analysis of two cases.Modern Pathology.  3:288-293. 1990
    1989 Conventional tram flap versus free microsurgical tram flap for immediate breast reconstructionPlastic and Reconstructive Surgery.  83:828-841. 1989
    1989 Conventional tram flap versus free microsurgical tram flap for immediate breast reconstructionPlastic and Reconstructive Surgery.  83:842-844. 1989
    1988 Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically.Cancer.  61:2077-2082. 1988
    1988 Thin Stage I Primary Cutaneous Malignant MelanomaNew England Journal of Medicine.  318:1159-1162. 1988
    1988 Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanomaJournal of Clinical Oncology.  6:1059-1065. 1988
    1988 In ReplyArchives of Surgery -New York-.  123:914. 1988
    1988 Prognostic significance of DNA aneuploidy in stage I cutaneous melanomaAnnals of Surgery.  207:455-461. 1988
    1988 Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographicallyCancer.  61:2077-2082. 1988
    1988 Resection of the liver for colorectal carcinoma metastases - A multi-institutional study of long-term survivorsDiseases of the Colon and Rectum.  31:1-4. 1988
    1988 Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: A phase I-II studyNCI monographs : a publication of the National Cancer Institute.  339-341. 1988
    1988 Total Pharyngeal Reconstruction Using a Pectoralis Major Myocutaneous TunnelArchives of Surgery -New York-.  123:391-393. 1988
    1987 Is modified radical neck dissection only a staging procedure?Cancer.  59:994-999. 1987
    1987 CURRENT STATUS OF NECK DISSECTION IN THE MANAGEMENT OF SQUAMOUS CARCINOMA OF THE HEAD AND NECKAustralian and New Zealand Journal of Surgery.  57:501-509. 1987
    1987 Does Radical Mastectomy Still Have a Place in the Treatment of Primary Operable Breast Cancer?Archives of Surgery -New York-.  122:1317-1320. 1987
    1987 Is modified radical neck dissection only a staging procedure?Cancer.  59:994-999. 1987
    1987 Modified radical neck dissection. Terminology, technique, and indicationsAmerican Journal of Surgery.  153:310-316. 1987
    1987 Squamous cell carcinoma of the buccal mucosa: Analysis of prognostic factorsAmerican Journal of Surgery.  154:411-414. 1987
    1986 Ultrasound of the breast. What are the indications?The Alabama journal of medical sciences.  23:192-195. 1986
    1986 Intraarterial chemotherapy for colorectal liver metastases and hepatomas using a totally implantable drug infusion pump.Recent Results in Cancer Research ==.  100:234-247. 1986
    1986 Malignant salivary tumors—analysis of prognostic factors and survivalHead & neck surgery.  9:82-92. 1986
    1986 Neck dissection with and without radiotherapy: Prognostic factors, patterns of recurrence, and survivalAmerican Journal of Surgery.  152:456-463. 1986
    1986 Surgery as palliative treatment for distant metastases of melanomaAnnals of Surgery.  204:181-185. 1986
    1986 Surgical treatment of early‐stage carcinoma of the oral tongue—would adjuvant treatment be beneficial?Head & neck surgery.  8:401-408. 1986
    1985 The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.Cancer.  55:1398-1402. 1985
    1985 Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patientsAnnals of Surgery.  201:465-469. 1985
    1985 The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanomaCancer.  55:1398-1402. 1985
    1984 Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and boneSurgery, gynecology & obstetrics.  158:545-551. 1984
    1984 [Intra-arterial chemotherapy using an implantable infusion pump in liver metastases of colorectal tumors and hepatomas].Chirurg.  55:485-493. 1984
    1984 Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatmentAnnals of Surgery.  200:769-775. 1984
    1984 Intraarterial chemotherapy with implanted infusion for hepatomas and liver metastasis of colorectal tumorsChirurg.  55:485-493. 1984
    1983 A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.Journal of Clinical Oncology.  1:720-726. 1983
    1983 [Completely implantable infusion pump. A new therapeutic possibility for selected patients with liver tumors].Deutsche Medizinische Wochenschrift.  108:1008-1013. 1983
    1983 Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients.Cancer.  51:2152-2156. 1983
    1983 Hepatocellular carcinoma: characteristics and current management.The Alabama journal of medical sciences.  20:182-185. 1983
    1983 A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pumpAnnals of Surgery.  198:567-573. 1983
    1983 A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patientsAnnals of Surgery.  198:207-212. 1983
    1983 Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patientsAmerican Journal of Surgery.  145:285-290. 1983
    1983 Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patientsCancer.  51:2152-2156. 1983
    1977 The nature of immune complexes in human cancer seraJournal of Immunology.  119:657-663. 1977
    1977 A rational approach to the surgical management of melanomaAnnals of Surgery.  186:481-490. 1977
    1977 In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapyJournal of Thoracic and Cardiovascular Surgery.  73:189-194. 1977
    1976 Capillary tube leukocyte adherence inhibition: An assay for cell‐mediated immunity in cancer patientsInternational Journal of Cancer.  17:338-341. 1976
    1976 Detection of human tumor‐associated antigens by the leukocyte migration in agarose assayInternational Journal of Cancer.  18:161-167. 1976
    1975 Cellular immunity to tumor associated antigens in sarcoma patients and their relativesSurgical Forum -Chicago-.  Vol. 26:154-156. 1975
    1975 Inhibition of leukocyte migration in agarose by KC1 extracts of a human melanoma cell line grown in serum‐free mediumInternational Journal of Cancer.  16:1035-1041. 1975

    Education And Training

  • Doctor of Medicine, University of Chicago 1971
  • Full Name

  • Marshall Urist